Characteristics, process measures and comparison of two cohorts before and after the development of new pathways
| Baseline | New | Total | P value | |
| (n=46) | (n=46) | (n=92) | ||
| Age | ||||
| Mean (SE mean) | 37 | 40 | 39 | 0.554 |
| Median (range) | (21–65) | (20–65) | (20–65) | |
| Gender, n (%) | ||||
| Male | 34 (74) | 36 (78) | 70 (76) | 0.807 |
| Female | 12 (26) | 10 (22) | 22 (24) | |
| Type of referral, n (%) | ||||
| Inpatient consult | 4 (9) | 17 (37) | 21 (23) | 0.000 |
| Primary care | 13 (28) | 24 (52) | 37 (37) | |
| ICP | 29 (63) | 5 (11) | 34 (40) | |
| Epilepsy diagnosis, n (%) | ||||
| New diagnosis | 1 (2) | 3 (7) | 4 (4) | 0.000 |
| Established diagnosis | 13 (28) | 26 (57) | 39 (42) | |
| No diagnosis | 0 | 4 (9) | 4 (4) | |
| Substance-related seizures | 3 (7) | 10 (22) | 13 (14) | |
| Unknown | 29 (63) | 3 (7) | 32 (35) | |
| Ability contact patient or communicate plan | 10 (22) | 46 (100) | 56 (61) | 0.000 |
| Ability to advise on management | 12 (26) | 46 (100) | 58 (63) | 0.000 |
| Change to management advised | 5 (11) | 27 (59) | 32 (35) | 0.000 |
ICP, Integrated Care Pathway.